Loading...
XASX
IME
Market cap11mUSD
Jun 11, Last price  
0.33AUD
1D
-1.52%
1Q
-15.58%
IPO
-100.00%
Name

ImExHS Ltd

Chart & Performance

D1W1MN
XASX:IME chart
P/E
—
P/S
0.66
EPS
—
Div Yield, %
—
Shrs. gr., 5y
18.56%
Rev. gr., 5y
27.99%
Revenues
27m
+35.08%
18,169,0006,374,0005,065,00012,028,0000000091,02080,1173,545,8495,779,8517,736,28710,913,96813,372,70917,117,35719,669,04326,569,437
Net income
-3m
L-37.38%
-13,898,000-29,499,000-1,904,000-1,418,000-344,552691,239-492,610-190,266-121,905-2,830,304-4,490,93568,469-4,887,165-6,002,288-3,615,977-4,699,772-3,038,653-4,192,339-2,625,449
CFO
-635k
L
000-2,657,513000000-3,651,460-109,862-1,541,439-4,089,807-1,467,042-2,968,041-2,198,7382,609,641-634,679
Earnings
Aug 28, 2025

Profile

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA.I, a set of artificial intelligence tools in the cloud that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. The company was incorporated in 2001 and is based in Mascot, Australia.
URL
http://omnimarkettide.com/
IPO date
Dec 14, 2005
Employees
300
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
26,569
35.08%
19,669
14.91%
17,117
28.00%
Cost of revenue
25,943
18,930
20,881
Unusual Expense (Income)
NOPBT
627
739
(3,763)
NOPBT Margin
2.36%
3.76%
Operating Taxes
58
173
92
Tax Rate
9.19%
23.36%
NOPAT
569
567
(3,856)
Net income
(2,625)
-37.38%
(4,192)
37.97%
(3,039)
-35.34%
Dividends
Dividend yield
Proceeds from repurchase of equity
(13)
3,250
BB yield
0.05%
-19.84%
Debt
Debt current
824
1,077
574
Long-term debt
395
243
572
Deferred revenue
543
Other long-term liabilities
79
(543)
Net debt
(853)
(1,041)
(1,394)
Cash flow
Cash from operating activities
(635)
2,610
(2,199)
CAPEX
(1,059)
(1,231)
(2,031)
Cash from investing activities
(766)
(2,133)
(2,222)
Cash from financing activities
1,181
(99)
2,252
FCF
2,057
1,086
(4,523)
Balance
Cash
2,072
2,362
1,912
Long term investments
628
Excess cash
744
1,378
1,684
Stockholders' equity
14,474
15,984
15,901
Invested Capital
14,998
15,898
15,309
ROIC
3.68%
3.63%
ROCE
3.98%
4.26%
EV
Common stock shares outstanding
44,956
41,738
35,600
Price
0.38
-44.03%
0.67
45.65%
0.46
-55.34%
Market cap
16,859
-39.71%
27,964
70.77%
16,376
-48.81%
EV
16,006
26,924
14,982
EBITDA
2,795
3,169
(2,004)
EV/EBITDA
5.73
8.50
Interest
332
443
Interest/NOPBT
44.93%